Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen.
Castellano E, Attanasio R, Giagulli VA, Boriano A, Terzolo M, Papini E, Guastamacchia E, Monti S, Aglialoro A, Agrimi D, Ansaldi E, Babini AC, Blatto A, Brancato D, Casile C, Cassibba S, Crescenti C, De Feo ML, Del Prete A, Disoteo O, Ermetici F, Fiore V, Fusco A, Gioia D, Grassi A, Gullo D, Lo Pomo F, Miceli A, Nizzoli M, Pellegrino M, Pirali B, Santini C, Settembrini S, Tortato E, Triggiani V, Vacirca A, Borretta G; all on behalf of Associazione Medici Endocrinologi (AME). Castellano E, et al. Among authors: fusco a. J Diabetes Metab Disord. 2018 Oct 1;17(2):393-399. doi: 10.1007/s40200-018-0358-2. eCollection 2018 Dec. J Diabetes Metab Disord. 2018. PMID: 30918874 Free PMC article.
Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen.
Castellano E, Attanasio R, Giagulli VA, Boriano A, Terzolo M, Papini E, Guastamacchia E, Monti S, Aglialoro A, Agrimi D, Ansaldi E, Babini AC, Blatto A, Brancato D, Casile C, Cassibba S, Crescenti C, De Feo ML, Del Prete A, Disoteo O, Ermetici F, Fiore V, Fusco A, Gioia D, Grassi A, Gullo D, Lo Pomo F, Miceli A, Nizzoli M, Pellegrino M, Pirali B, Santini C, Settembrini S, Tortato E, Triggiani V, Vacirca A, Borretta G; all on behalf of Associazione Medici Endocrinologi (AME). Castellano E, et al. Among authors: fusco a. J Diabetes Metab Disord. 2018 Dec 17;17(2):401-402. doi: 10.1007/s40200-018-0370-6. eCollection 2018 Dec. J Diabetes Metab Disord. 2018. PMID: 30919831 Free PMC article.
Older Adults with Type 2 Diabetes Treated with Metformin: AME-MET Study - A Multicentric Real-world Study in Italy.
Elena C, Borretta G, Attanasio R, Alberto B, Agrimi D, Argese N, Crescenti C, Disoteo O, Fusco A, Gabellieri E, Guglielmi R, Lisco G, Lo Pomo F, Nizzoli M, Panico A, Pirali B, Salcuni AS, Turchi F, Grimaldi F. Elena C, et al. Among authors: fusco a. Endocr Metab Immune Disord Drug Targets. 2023;23(6):818-825. doi: 10.2174/1871530323666221115091621. Endocr Metab Immune Disord Drug Targets. 2023. PMID: 36380441 Free PMC article.
Obesity in Prediabetic Patients: Management of Metabolic Complications and Strategies for Prevention of Overt Diabetes.
Chianelli M, Armellini M, Carpentieri M, Coccaro C, Cuttica CM, Fusco A, Marucci S, Nelva A, Nizzoli M, Ponziani MC, Sciaraffia M, Tassone F, Busetto L. Chianelli M, et al. Among authors: fusco a. Endocr Metab Immune Disord Drug Targets. 2024 May 20. doi: 10.2174/0118715303282327240507184902. Online ahead of print. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 38778593
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy.
Gentile S, Guarino G, Corte TD, Marino G, Fusco A, Corigliano G, Colarusso S, Piscopo M, Improta MR, Corigliano M, MartedÌ E, Oliva D, Russo V, Simonetti R, Satta E, Romano C, Alfarone C, Vetrano A, Martino C, Lamberti C, Vecchiato A, Cozzolino G, Brancario C, Strollo F; AMD-OSDI Study Group on Injection Techniques and Nefrocenter Research & Nyx Start-up Study Group. Gentile S, et al. Among authors: fusco a. Diabetes Ther. 2020 Sep;11(9):2001-2017. doi: 10.1007/s13300-020-00876-0. Epub 2020 Jul 18. Diabetes Ther. 2020. PMID: 32683659 Free PMC article.
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes.
Gentile S, Guarino G, Della Corte T, Marino G, Fusco A, Corigliano G, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedi E, Oliva D, Russo V, Simonetti R, Satta E, Romano C, Vaia S, Strollo F; AMD-OSDI Study Group on Injection Techniques; Nefrocenter Network and Nyx Start-up Study Group. Gentile S, et al. Among authors: fusco a. Diabetes Ther. 2021 Jan;12(1):107-119. doi: 10.1007/s13300-020-00954-3. Epub 2020 Nov 21. Diabetes Ther. 2021. PMID: 33219928 Free PMC article. Review.
A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence.
Gentile S, Fusco A, Colarusso S, Piscopo M, Improta MR, Corigliano M, Martedi E, Oliva D, Santorelli A, Simonetti R, Giammarco A, Colella C, Miretto L, D'Alessandro A, Russo V, Guarino G, Marino G, Corigliano G, Strollo F. Gentile S, et al. Among authors: fusco a. Expert Opin Drug Saf. 2018 May;17(5):445-450. doi: 10.1080/14740338.2018.1453495. Epub 2018 Apr 18. Expert Opin Drug Saf. 2018. PMID: 29564932 Clinical Trial.
1,154 results